Is Plena Health profitable?

No profitability data is public. Plena, a 2025-founded YC P2026 startup, claims (vendor-claimed) seven figures in committed ARR and 17x growth in 10 months as of June 2026, but no independent financials or profitability figures have been verified by third parties.

Could AI replace Plena Health's product itself?

Plena's own business is an AI layer automating referrals, scheduling, and billing; frontier AI feeds this integration layer rather than replacing it, but larger platforms like Epic and Abridge could absorb the same workflows, per a 2026-07-19 competitive analysis.

Who is Plena Health's biggest competitor?

Abridge is the named threat: it raised about 550 million dollars in 2025 rounds reaching a 5.3 billion dollar valuation and is expanding from clinical documentation into revenue-cycle, coding, and prior-authorization, directly overlapping Plena's core workflows, as of 2025-07-21.

Who owns Plena Health?

Plena Health is privately held, founded in 2025 by CEO Eyad Abdalla and CTO Ahmed Al Mudarris, and backed by Y Combinator's P2026 batch; no other investors or funding rounds have been publicly confirmed as of 2026-07-21.

How fast is Plena Health growing?

Plena claims (vendor-claimed) 17x growth in 10 months and crossing seven figures in committed ARR across six specialties and eight U.S. states, with about 80 percent of growth from word-of-mouth, as stated in its YC launch on 2026-06-01.

Does Plena Health integrate with electronic health record systems?

Plena claims (vendor-claimed) integration with more than 40 EMRs and 10x faster referral processing, according to its own product marketing dated 2026-06-01; these figures have not been independently verified by third parties.

YC Spring 2026 · United States

Plena Health

Software that automates admin work (referrals, scheduling, billing) for specialty medical practices.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from within 12-18 months · Every call on the record Checkpoint: Abridge ships a revenue-cycle or prior-authorization product aimed at small practices, not just hospitals

The call

Plena has early traction in a real niche, but its main rival is racing toward the same customers from a much stronger financial position.

Plena helps small independent medical clinics handle paperwork like coding, insurance approvals, and billing by using AI to read doctor notes and fill out forms automatically. Right now, Plena is not hard to copy or replace because it does not yet own customers so deeply that they cannot switch. The real danger is Abridge, a much larger competitor that already works with major hospital systems and is now building the exact same coding and insurance-approval tools that Plena sells. The one thing that could save Plena is if it locks in small independent clinics (the ones that do not use Epic hospital software) as loyal customers before Abridge reaches them in the next year or so, but that window is closing.

Why

AI pressure: Abridge. Abridge's ambient AI scribe is pushing into coding and revenue-cycle work, the same tasks Plena automates. Could AI do the core job? Only partly.

Bigger players: Epic. Epic controls the records system most practices run on and could bundle its own AI scribe and admin tools for free. Could a giant copy it? Yes, easily.

What protects it. Deep connections into small independent clinics that big EMR vendors and health-system-focused rivals tend to skip.

What would change this call

Abridge announces a revenue-cycle or prior-authorization product shipped to small independent specialty clinics within 12-18 months. Would show Abridge closing the window before Plena locks in specialty workflow ownership.
Plena publishes named-customer, multi-year retention data or third-party verified EMR-connector depth within 12 months. Would show Plena converting early traction into a real workflow moat.
Epic ships or expands its own AI scribe with pricing aimed at specialty practices. Would show a second incumbent squeezing Plena's target segment from the EMR side.

Key numbers

Plena claims 17x growth in 10 months (2026-06-01)
Abridge raised about $550M at a $5.3B valuation (2026-07-19)
Plena says it integrates with 40+ EMR systems (2026-06-01)

Named risks

Abridge expanding into revenue-cycle, coding, and prior-authorization threatens Plena's core turf. Severity: high
Epic's rumored proprietary AI scribe and Toolbox partnerships could compress category pricing and integration edge. Severity: high
No third-party verified customer logos, funding, or headcount undermines traction claims. Severity: medium
Crowded YC P2026 batch of near-identical peers increases consolidation and pivot risk. Severity: medium
Conflicting public data on HQ location and funding status raises verification concerns. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Abridge	losing to	Expanding from documentation into revenue-cycle, coding, prior-auth via Epic revenue-share deal, 2025-07-21
Epic Systems	losing to	Signaled proprietary AI scribe plans and expanded Toolbox partnerships in 2025, per report dated 2026-07-19
Ambience Healthcare	contesting	Holds ~13% ambient-scribing market share per Menlo Ventures, 2025-10-21
Arctic Health, Taiga, Beacon Health, Novoflow, Aegis, Insurf	contesting	Six near-identical YC P2026 healthcare-admin-automation peers listed 2026-07-22

Questions people ask

Is Plena Health profitable?: No profitability data is public. Plena, a 2025-founded YC P2026 startup, claims (vendor-claimed) seven figures in committed ARR and 17x growth in 10 months as of June 2026, but no independent financials or profitability figures have been verified by third parties.
Could AI replace Plena Health's product itself?: Plena's own business is an AI layer automating referrals, scheduling, and billing; frontier AI feeds this integration layer rather than replacing it, but larger platforms like Epic and Abridge could absorb the same workflows, per a 2026-07-19 competitive analysis.
Who is Plena Health's biggest competitor?: Abridge is the named threat: it raised about 550 million dollars in 2025 rounds reaching a 5.3 billion dollar valuation and is expanding from clinical documentation into revenue-cycle, coding, and prior-authorization, directly overlapping Plena's core workflows, as of 2025-07-21.
Who owns Plena Health?: Plena Health is privately held, founded in 2025 by CEO Eyad Abdalla and CTO Ahmed Al Mudarris, and backed by Y Combinator's P2026 batch; no other investors or funding rounds have been publicly confirmed as of 2026-07-21.
How fast is Plena Health growing?: Plena claims (vendor-claimed) 17x growth in 10 months and crossing seven figures in committed ARR across six specialties and eight U.S. states, with about 80 percent of growth from word-of-mouth, as stated in its YC launch on 2026-06-01.
Does Plena Health integrate with electronic health record systems?: Plena claims (vendor-claimed) integration with more than 40 EMRs and 10x faster referral processing, according to its own product marketing dated 2026-06-01; these figures have not been independently verified by third parties.

Timeline

2026-07-22YC directory lists six P2026 healthcare-admin peers competing with Plena
2026-07-21Third-party sources show no verified funding, headcount, or customer logos for Plena
2026-07-19Analysis details Abridge's $550M 2025 raises and $5.3B valuation as top threat
2026-07-13YC directory lists Plena Health as San Francisco based, P2026 batch
2026-06-01Plena launches on YC, claims 17x growth and seven-figure committed ARR
2025-08-01Epic signals plans for proprietary AI scribe at Users Group Meeting
2025-07-21Report details Abridge's Epic revenue-share deal and expansion into revenue-cycle
2025Plena Health founded by Eyad Abdalla and Ahmed Al Mudarris

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Trellis Surtr Defense Systems HeyClicky